Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Polycystic Ovarian Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global polycystic ovarian syndrome treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. 

Polycystic ovarian syndrome (PCOS) refers to a hormonal disorder that leads to the abnormal and excessive production of male hormones in females. It is characterized by hyperandrogenism, ovulatory dysfunction and the development of polycystic ovaries. The disorder can also cause acne, darkening of the skin, weight gain and missed or irregular menstrual cycles, leading to infertility and development of cysts or small fluid-filled sacs in the ovaries. Some of the commonly used treatment methods for regulating and managing PCOS include oral contraceptives, antiandrogens, insulin-sensitizing agents, antidepressants and anti-obesity medicines, along with various surgical procedures, such as ovarian wedge resection and laparoscopic ovarian drilling.

The increasing prevalence of PCOS across the globe represents one of the key factors driving the growth of the market. Furthermore, rising health consciousness and increasing awareness regarding the available treatment alternatives for PCOS are also driving the market growth. PCOS often leads to hirsutism, obesity, diabetes, infertility and other chronic ailments, which has enhanced the requirement for effective treatment alternatives to manage the disease efficiently. In line with this, widespread adoption of laparoscopic ovarian drilling, which involves the surgical triggering of ovulation in women, as an effective treatment for PCOS, is also contributing to the market growth. Additionally, various technological advancements, such as the development of improved pharmacological agents, including androgen suppressors and peripheral androgen blockers, are also favoring the market growth. Other factors, including rising healthcare expenditure of the individuals, along with extensive research and development (R&D) activities, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global polycystic ovarian syndrome treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, drug class, surgery type and distribution channel.

Breakup by Drug Class:

  • Oral Contraceptives
  • Antiandrogens
  • Insulin-sensitizing Agent
  • Antidepressant
  • Anti-obesity
  • Others
     

Breakup by Surgery Type:

  • Ovarian Wedge Resection
  • Laparoscopic Ovarian Drilling
     

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Stores
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Ferring B.V., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Class, Surgery Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Company, Ferring B.V., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Teva Pharmaceutical Industries Ltd
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global polycystic ovarian syndrome treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polycystic ovarian syndrome treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the surgery type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polycystic ovarian syndrome treatment market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Polycystic Ovarian Syndrome Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Oral Contraceptives
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Antiandrogens
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Insulin-sensitizing Agent
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Antidepressant
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Anti-obesity
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Surgery Type
    7.1    Ovarian Wedge Resection
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Laparoscopic Ovarian Drilling
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
          9.5.1 Market Trends
          9.5.2 Market Breakup by Country
          9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    AstraZeneca Plc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Bayer AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Ferring B.V.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
        14.3.6    Merck KGaA
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Novartis AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi S.A.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Polycystic Ovarian Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Drug Class (in %), 2020
Figure 5: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Surgery Type (in %), 2020
Figure 6: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Polycystic Ovarian Syndrome Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Polycystic Ovarian Syndrome Treatment (Oral Contraceptives) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Polycystic Ovarian Syndrome Treatment (Oral Contraceptives) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Polycystic Ovarian Syndrome Treatment (Antiandrogens) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Polycystic Ovarian Syndrome Treatment (Antiandrogens) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Polycystic Ovarian Syndrome Treatment (Insulin-sensitizing Agent) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Polycystic Ovarian Syndrome Treatment (Insulin-sensitizing Agent) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Polycystic Ovarian Syndrome Treatment (Antidepressant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Polycystic Ovarian Syndrome Treatment (Antidepressant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Polycystic Ovarian Syndrome Treatment (Anti-obesity) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Polycystic Ovarian Syndrome Treatment (Anti-obesity) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Polycystic Ovarian Syndrome Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Polycystic Ovarian Syndrome Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Polycystic Ovarian Syndrome Treatment (Ovarian Wedge Resection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Polycystic Ovarian Syndrome Treatment (Ovarian Wedge Resection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Polycystic Ovarian Syndrome Treatment (Laparoscopic Ovarian Drilling) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Polycystic Ovarian Syndrome Treatment (Laparoscopic Ovarian Drilling) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Polycystic Ovarian Syndrome Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Polycystic Ovarian Syndrome Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Polycystic Ovarian Syndrome Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Polycystic Ovarian Syndrome Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Polycystic Ovarian Syndrome Treatment (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Polycystic Ovarian Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Polycystic Ovarian Syndrome Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Polycystic Ovarian Syndrome Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia Pacific: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia Pacific: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Polycystic Ovarian Syndrome Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Polycystic Ovarian Syndrome Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Global: Polycystic Ovarian Syndrome Treatment Industry: SWOT Analysis
Figure 81: Global: Polycystic Ovarian Syndrome Treatment Industry: Value Chain Analysis
Figure 82: Global: Polycystic Ovarian Syndrome Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Polycystic Ovarian Syndrome Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Surgery Type (in Million US$), 2021-2026
Table 4: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Polycystic Ovarian Syndrome Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Polycystic Ovarian Syndrome Treatment Market: Competitive Structure
Table 7: Global: Polycystic Ovarian Syndrome Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links